India, March 13 -- Shares of Lifeward Ltd. (LFWD) surged nearly 75% on Thursday morning after receiving 510(k) FDA clearance for the newest generation of its exoskeleton device, the ReWalk 7.
LFWD is currently trading at $2.5700, up $1.1000 or 74.83%, on the Nasdaq. The stock opened its trading at $1.7400 after closing Wednesday at $1.4700. The stock has traded between $1.2500 and $6.0000 in the past 52-week period.
The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury (SCI) to stand and walk again, includes several new features, as well as enhancements and upgrades.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
"FDA clearance is a major milest...